Drug Profile


Alternative Names: CGS 9343B; KW 5617; ZY 17617B

Latest Information Update: 27 Oct 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novartis Consumer Health
  • Class Antidiarrhoeals
  • Mechanism of Action Calmodulin antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Diarrhoea

Most Recent Events

  • 27 Oct 1999 Profile was reviewed by Novartis Consumer Health SA on 19 Oct 1999
  • 27 Oct 1999 Zaldaride is available for licensing
  • 19 Oct 1999 Discontinued-I for Diarrhoea in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top